These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17895574)

  • 1. Metabolic syndrome and medical expenditure in Japan.
    Oda E
    Circ J; 2007 Oct; 71(10):1666; author reply 1667. PubMed ID: 17895574
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of combined cardiovascular risk factors on individual and population medical expenditures: a 10-year cohort study of national health insurance in a Japanese population.
    Okamura T; Nakamura K; Kanda H; Hayakawa T; Hozawa A; Murakami Y; Kadowaki T; Kita Y; Okayama A; Ueshima H;
    Circ J; 2007 Jun; 71(6):807-13. PubMed ID: 17526973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cardiovascular risk factors on individual and population medical expenditures: a 10-year cohort study of 4,535 National Health Insurance beneficiaries in Shiga].
    Okamura T; Nakamura K; Hayakawa T; Kanda H; Miura K; Okayama A; Ueshima H
    Nihon Eiseigaku Zasshi; 2012 Jan; 67(1):38-43. PubMed ID: 22449821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome.
    Kohro T; Furui Y; Mitsutake N; Fujii R; Morita H; Oku S; Ohe K; Nagai R
    Int Heart J; 2008 Mar; 49(2):193-203. PubMed ID: 18475019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and attribute of each obesity-related cardiovascular risk factor in combination with abdominal obesity on total health expenditures in adult Japanese National Health insurance beneficiaries: The Ibaraki Prefectural health study.
    Sairenchi T; Iso H; Yamagishi K; Irie F; Nagao M; Umesawa M; Haruyama Y; Kobashi G; Watanabe H; Ota H
    J Epidemiol; 2017 Aug; 27(8):354-359. PubMed ID: 28258883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome, Physical Activity, and Medication-Related Expenditures: A Longitudinal Analysis.
    Lemes ÍR; Fernandes RA; Turi-Lynch BC; Codogno JS; de Morais LC; Koyama KAK; Monteiro HL
    J Phys Act Health; 2019 Oct; 16(10):830-835. PubMed ID: 31365903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular risks in adolescents with different degrees of obesity.
    Torres KP; Torres SG; Guerra RO
    Arq Bras Cardiol; 2011 Aug; 97(2):179; author reply 180. PubMed ID: 22002030
    [No Abstract]   [Full Text] [Related]  

  • 10. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease.
    Reaven G
    Clin Chem; 2008 May; 54(5):785-7. PubMed ID: 18375479
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction to the Obesity, Metabolic Syndrome, and CVD Compendium.
    Moore KJ; Shah R
    Circ Res; 2020 May; 126(11):1475-1476. PubMed ID: 32437304
    [No Abstract]   [Full Text] [Related]  

  • 12. The joint impact of cardiovascular risk factors upon medical costs.
    Ohmori-Matsuda K; Kuriyama S; Hozawa A; Nakaya N; Shimazu T; Tsuji I
    Prev Med; 2007 Apr; 44(4):349-55. PubMed ID: 17289136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New targets in patients with cardiometabolic risk].
    Ruilope LM; Carmena R
    Med Clin (Barc); 2007 Oct; 129(15):576-7. PubMed ID: 17988615
    [No Abstract]   [Full Text] [Related]  

  • 14. Age-stratified analysis of the impact of hypertension on National Health Insurance Medical Expenditures in Ibaraki, Japan.
    Sairenchi T; Irie F; Izumi Y; Muto T
    J Epidemiol; 2010; 20(3):192-6. PubMed ID: 20208401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity-related risk factors of cardiovascular disease.
    Oda E
    Circ J; 2009 Dec; 73(12):2204-5. PubMed ID: 19940368
    [No Abstract]   [Full Text] [Related]  

  • 16. The Reply.
    Salazar MR; Reaven GM
    Am J Med; 2015 Jul; 128(7):e27. PubMed ID: 26092075
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipidemia and Medical Expenditures by Cardiovascular Disease Status in US Adults.
    Zhang D; Wang G; Fang J; Mercado C
    Med Care; 2017 Jan; 55(1):4-11. PubMed ID: 27787352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the Visceral Adiposity Index in Different Populations.
    Peng TC; Chen WL; Kao TW
    Am J Med; 2015 Jul; 128(7):e25-6. PubMed ID: 26092074
    [No Abstract]   [Full Text] [Related]  

  • 19. Refined method for estimating medical expenditures for liver disease using the patient survey and claim data in Japan.
    Toyokawai S; Kobayashi Y; Ohmori M
    Nihon Koshu Eisei Zasshi; 2005 Nov; 52(11):957-61. PubMed ID: 16408480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point: the metabolic syndrome still lives.
    Grundy SM
    Clin Chem; 2005 Aug; 51(8):1352-4. PubMed ID: 16040840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.